AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TICAGRELOR 90 Mg ;

10 registrations across 1 African market— 10 active

Markets with TICAGRELOR 90 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Egygrelor
Oro-dispersible tablet
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Brilique 90 mg
Film Coated Tablets
🇪🇬EgyptAstrazeneca scientific officeactive
Thrombolinta
Film Coated Tablets
🇪🇬EgyptGlobal NAPI Pharmaceuticals - GNPactive
Egygrelor
Oro-dispersible tablet
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Grelovixen
Oro-dispersible tablet
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive
Lingabrique
Oro-dispersible tablet
🇪🇬EgyptUtopia pharmaceuticalsactive
Lingabrique
Oro-dispersible tablet
🇪🇬EgyptUtopia pharmaceuticalsactive
Biogrelor 90mg
Film Coated Tablets
🇪🇬EgyptTrust Business Pharmaactive
Brilique 90 mg
Film Coated Tablets
🇪🇬EgyptAstrazeneca scientific officeactive
Atherogrel 90mg
Film Coated Tablets
🇪🇬EgyptSAJA Pharmaceuticals Egypt - SAJAactive

TICAGRELOR 90 Mg ; in Africa — Regulatory Overview

TICAGRELOR 90 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.